These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2786143)

  • 1. Transplantation advances in Parkinson's disease.
    Sladek JR; Redmond DE; Collier TJ; Elsworth JD; Roth RH
    Mov Disord; 1989; 4 Suppl 1():S120-5. PubMed ID: 2786143
    [No Abstract]   [Full Text] [Related]  

  • 2. Nigral and adrenal grafts in parkinsonism: recent basic and clinical studies.
    Olson L; Backlund EO; Gerhardt G; Hoffer B; Lindvall O; Rose G; Seiger A; Strömberg I
    Adv Neurol; 1987; 45():85-94. PubMed ID: 3030073
    [No Abstract]   [Full Text] [Related]  

  • 3. Fetal-tissue transplants in Parkinson's disease.
    Fahn S
    N Engl J Med; 1992 Nov; 327(22):1589-90. PubMed ID: 1435887
    [No Abstract]   [Full Text] [Related]  

  • 4. Subclinical damage to the nigrostriatal dopamine system by MPTP as a model of preclinical Parkinson's disease: a review.
    Burns RS
    Acta Neurol Scand Suppl; 1991; 136():29-36. PubMed ID: 1801534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal nondopaminergic neural implants in parkinsonian primates. Histochemical and behavioral studies.
    Bankiewicz KS; Plunkett RJ; Jacobowitz DM; Kopin IJ; Oldfield EH
    J Neurosurg; 1991 Jan; 74(1):97-104. PubMed ID: 1670609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.
    Graybiel AM; Moratalla R; Quinn B; DeLanney LE; Irwin I; Langston JW
    Adv Neurol; 1993; 60():34-9. PubMed ID: 8420148
    [No Abstract]   [Full Text] [Related]  

  • 7. Transplantation of autologous superior cervical ganglion into the brain of parkinsonian monkeys.
    Nakai M; Itakura T; Komai N
    Stereotact Funct Neurosurg; 1990; 54-55():337-41. PubMed ID: 2080350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man.
    Burns RS; Markey SP; Phillips JM; Chiueh CC
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):166-8. PubMed ID: 6608980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvements in MPTP-induced object retrieval deficits and behavioral deficits after fetal nigral grafting in monkeys.
    Taylor JR; Elsworth JD; Roth RH; Collier TJ; Sladek JR; Redmond DE
    Prog Brain Res; 1990; 82():543-59. PubMed ID: 2290957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and animal studies of Parkinson's disease.
    Oertel WH; Kupsch A
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal transplantation in parkinsonism.
    Itakura T
    Jpn J Psychiatry Neurol; 1991 Jun; 45(2):515-6. PubMed ID: 1762259
    [No Abstract]   [Full Text] [Related]  

  • 12. Features of the parkinsonian syndrome induced experimentally by a deficit of nigrostriatal dopamine and stimulation of cholinergic neurons of the caudate nuclei.
    Kryzhanovskii GN; Atadzhanov MA; Voronina TA; Nerobkova LN
    Neurosci Behav Physiol; 1994; 24(6):485-8. PubMed ID: 7715769
    [No Abstract]   [Full Text] [Related]  

  • 13. An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.
    Waters CM; Hunt SP; Jenner P; Marsden CD
    Neuroscience; 1987 Dec; 23(3):1025-39. PubMed ID: 2893993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of hemiparkinsonian syndrome in nonhuman primates by amnion implantation into caudate nucleus.
    Bankiewicz KS; Palmatier M; Plunkett RJ; Cummins A; Oldfield EH
    J Neurosurg; 1994 Dec; 81(6):869-76. PubMed ID: 7965117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of Parkinson's disease.
    Riederer P; Lange KW
    Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):295-300. PubMed ID: 1623255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trophism, transplantation, and animal models of Parkinson's disease.
    Bankiewicz K; Mandel RJ; Sofroniew MV
    Exp Neurol; 1993 Nov; 124(1):140-9. PubMed ID: 8282071
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease].
    Lange KW
    Fortschr Neurol Psychiatr; 1989 Apr; 57(4):142-8. PubMed ID: 2656447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efferent synaptic connections of dopaminergic neurons grafted into the caudate nucleus of experimentally induced parkinsonian monkeys are different from those of control animals.
    Leranth C; Sladek JR; Roth RH; Redmond DE
    Exp Brain Res; 1998 Dec; 123(3):323-33. PubMed ID: 9860271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of fetal dopamine neurons in primate brain reverses MPTP induced parkinsonism.
    Sladek JR; Redmond DE; Collier TJ; Haber SN; Elsworth JD; Deutch AY; Roth RH
    Prog Brain Res; 1987; 71():309-23. PubMed ID: 3495818
    [No Abstract]   [Full Text] [Related]  

  • 20. [Behaviour after transplantation of brain cells into monkey models of Parkinson's disease].
    Liu ZG; Chen S; Yu H
    Zhonghua Yi Xue Za Zhi; 1997 Sep; 77(9):683-6. PubMed ID: 9772539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.